Literature DB >> 6258762

Histological observations on the failure of rachitic rat bones to respond to 1,25/OH)2D3.

J A Gallagher, D E Lawson.   

Abstract

Rachitic rats, maintained on diets with low or normal P contents, were given daily intraperitoneal doses of 1,25(OH)2D3 or 25OHD3 at levels of 100 or 200 ng. Plasma chemistry was measured and the ash content and histological appearance of the bones investigated. Using labeled material it was shown that the dosing levels of 1,25(OH)2D3 employed ensured a higher than normal plasma concentration of that metabolite over the period between doses. 1,25(OH)2D3 was not effective as 25OHD3 in raising bone ash or reducing the amount of osteoid. The difference between the effects of the metabolites was evident at both dietary P levels, but more marked at the higher P level. In contrast, the metabolites reduced the width of the epiphyseal plate to an approximately similar degree, and this is possibly the reason why there are discrepancies between previous reports of the effectiveness of 1,25(OH)2D3 compared with 25OHD3 or vitamin D3. Dosing with 1,25(OH)2D3 failed to maintain a constant plasma Pi value over the period between doses in animals fed the low P diet.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6258762     DOI: 10.1007/bf02407184

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  19 in total

1.  Bone-resorbing activity of analogues of 25-hydroxycholecalciferol and 1,25-dihydroxycholecalciferol: effects of side chain modification and stereoisomerization on responses of fetal rat bones in vitro.

Authors:  P H Stern; T Mavreas
Journal:  Mol Pharmacol       Date:  1976-11       Impact factor: 4.436

2.  Vitamin D and growth.

Authors:  H STEENBOCK; D C HERTING
Journal:  J Nutr       Date:  1955-12-10       Impact factor: 4.798

3.  The use of radioactive phosphorus in the assay of vitamin D.

Authors:  P NUMEROF; H L SASSAMAN; A RODGERS; A E SCHAEFER
Journal:  J Nutr       Date:  1955-01       Impact factor: 4.798

4.  Biological activity of the vitamin D metabolite 1,25-dihydroxycholecalciferol in chickens and rats.

Authors:  A W Norman; R G Wong
Journal:  J Nutr       Date:  1972-12       Impact factor: 4.798

5.  Silver staining of bone prior to decalcification for quantitative determination of osteoid in sections.

Authors:  E J Tripp; E H MacKay
Journal:  Stain Technol       Date:  1972-05

6.  Comparison of 1 alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: greater effect of 25-hydroxycholecalciferol on bone mineralization.

Authors:  A Fournier; P Bordier; J Gueris; J L Sebert; P Marie; C Ferrière; J Bedrossian; H F DeLuca
Journal:  Kidney Int       Date:  1979-02       Impact factor: 10.612

7.  24, 25-dihydroxyvitamin D is a metabolite of vitamin D essential for bone formation.

Authors:  A Ornoy; D Goodwin; D Noff; S Edelstein
Journal:  Nature       Date:  1978-11-30       Impact factor: 49.962

8.  The mobilization of bone mineral by 1,25-dihydroxyvitamin D3 in hypophosphatemic rats.

Authors:  L Castillo; Y Tanaka; H F DeLuca
Journal:  Endocrinology       Date:  1975-10       Impact factor: 4.736

9.  The effect of 1alpha(OH)D3 and 1alpha,25(OH)2D3 on the bone in patients with renal osteodystrophy.

Authors:  P Bordier; J Zingraff; J Gueris; P Jungers; P Marie; M Pechet; H Rasmussen
Journal:  Am J Med       Date:  1978-01       Impact factor: 4.965

10.  Ultrastructural evaluation of the effects of 1,25-dihydroxyvitamin D3 on bone of thyroparathyroidectomized rats fed a low-calcium diet.

Authors:  S E Weisbrode; C C Capen; A W Norman
Journal:  Am J Pathol       Date:  1978-08       Impact factor: 4.307

View more
  7 in total

1.  The dichotomy in the effects of 1,25 dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on bone gamma-carboxyglutamic acid-containing protein in serum and bone in vitamin D-deficient rats.

Authors:  S Wientroub; P A Price; A H Reddi
Journal:  Calcif Tissue Int       Date:  1987-03       Impact factor: 4.333

2.  The influence of dihydroxylated vitamin D metabolites on bone formation in the chick.

Authors:  I R Dickson; A K Hall; S S Jande
Journal:  Calcif Tissue Int       Date:  1984-01       Impact factor: 4.333

3.  Effects of 1,25-dihydroxycholecalciferol on fracture healing. Calcium, phosphate, and zinc in callus and serum.

Authors:  O Andreen; S E Larsson
Journal:  Arch Orthop Trauma Surg       Date:  1984

4.  Calcitriol but no other metabolite of vitamin D is essential for normal bone growth and development in the rat.

Authors:  A M Parfitt; C H Mathews; R Brommage; K Jarnagin; H F DeLuca
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

5.  Autoradiographic localization of target cells for 1 alpha, 25-dihydroxyvitamin D3 in bones from fetal rats.

Authors:  R Narbaitz; W E Stumpf; M Sar; S Huang; H F DeLuca
Journal:  Calcif Tissue Int       Date:  1983       Impact factor: 4.333

6.  Increase of bone volume in vitamin D-repleted rats by massive administration of 24R,25(OH)2D3.

Authors:  T Nakamura; T Kurokawa; H Orimo
Journal:  Calcif Tissue Int       Date:  1988-10       Impact factor: 4.333

7.  Vitamin D and hyperparathyroidism: the Lumleian Lecture 1981.

Authors:  S W Stanbury
Journal:  J R Coll Physicians Lond       Date:  1981-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.